search
press releases
awards
in the news
Regional updates: are you ready for the new regulations?
TriOptima will be hosting a series of regional roundtables on the outlined CFTC and EMIR regulations. The implications of the new rules will be discussed and you will find out what the industry is doing to comply with the requir
NEWS
TRIRESOLVE
CFTC clearing relief for compression-related partial terminations & replacement trades
On March 18th, CFTC’s Division of Clearing and Risk issued a No-Action Relief from required clearing of swaps that are generated as part of multilateral portfolio compression exercises, including both partially terminated
NEWS
TRIREDUCE
ESMA OKs Compression-Related Uncovered Sovereign CDS Replacement Trades
On 30 January, the European Securities and Markets Authority (ESMA) published 2nd Update of Q&A on the application of the Short Selling Regulation(SSR) which clarified that replacement trades resulting from compressions are
NEWS
TRIREDUCE
1 2 3 4
home > news
TriOptima news

Regional updates: are you ready for the new regulations?


TriOptima will be hosting a series of regional roundtables on the outlined CFTC and EMIR regulations. The implications of the new rules will be discussed and you will find out what the industry is doing to comply with the requirements for reconciliation and dispute resolution.


Date 

 Location
2012

  
23 Oct Singapore
07 Nov  Zurich
19 Nov  Frankfurt
27 Nov  Madrid
10 Dec  Lisbon
11 Dec  Vienna
12 Dec  Milan


2013

  
24 Jan  Brussels
05 Feb  Essen
06 Feb  Athens
26 Feb  New York
27 Feb  Paris
04 Mar  Amsterdam
13 Mar  Helsinki
17 Mar Summerlin
18 Mar  Frankfurt
20 Mar  London
26 Mar Korea
05 Apr Boston
11 Apr Geneva
18 Apr Hong Kong
29 Apr Sydney
09 May Chicago
14 May Houston
30 May Paris
12 Jun Calgary
13 Jun London
tbc Singapore
tbc Munich
tbc Hamburg
tbc Madrid
tbc Dublin
tbc Luxembourg

 

 

 

 







 





 

 

 


















Provisional Agenda

Impact of regulations
triResolve roadmap
Workshop: preparing for regulation
Networking drinks

For further information or to RSVP to one of the events, please email us. Alternatively, should you be interested in hosting a roundtable in a city not listed, we would be delighted to hear from you. 







time
New York office
+1 646 744 0400		 time
London office
+44 20 7382 2200		 time
Stockholm office
+46 8 545 25 130		 time
Singapore office
+65 6372 8181
time
Tokyo office
+81 3 6450 1350
 TriOptima logo
 
 triResolve portfolio reconciliation & counterparty exposure management | triReduce portfolio compression & early termination | triBalance counterparty risk rebalancing

© 2004-2013 TriOptima AB, an ICAP Group Company. All rights reserved | Terms of use | Privacy statement | Site map | Info security | Site build
Please enter your full name.

Disclaimer
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use


1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.


2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.


    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.


3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.


    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.


4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.


    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.


    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.


    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.


    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.


    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.


5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.


6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline